BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 25560471)

  • 1. Impact of VEGF gene polymorphisms in elderly cancer patients: clinical outcome and toxicity.
    Della-Morte D; Riondino S; Ferroni P; Palmirotta R; Pastore D; Lauro D; Guadagni F; Roselli M
    Pharmacogenomics; 2015 Jan; 16(1):61-78. PubMed ID: 25560471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic and predictive role of vascular endothelial growth factor polymorphisms in breast cancer.
    Koutras A; Kotoula V; Fountzilas G
    Pharmacogenomics; 2015 Jan; 16(1):79-94. PubMed ID: 25560472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Angiogenic Drugs, Vascular Toxicity and Thromboembolism in Solid Cancer.
    Riondino S; Del Monte G; Fratangeli F; Guadagni F; Roselli M; Ferroni P
    Cardiovasc Hematol Agents Med Chem; 2017; 15(1):3-16. PubMed ID: 28137223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between proangiogenic gene expression levels in prostate cancer and their prognostic value for clinical outcomes.
    Mori R; Dorff TB; Xiong S; Tarabolous CJ; Ye W; Groshen S; Danenberg KD; Danenberg PV; Pinski JK
    Prostate; 2010 Nov; 70(15):1692-700. PubMed ID: 20564320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor gene polymorphisms in ovarian cancer.
    Polterauer S; Grimm C; Mustea A; Concin N; Tanner B; Thiel F; Heinze G; Reinthaller A; Zeillinger R; Hefler LA
    Gynecol Oncol; 2007 May; 105(2):385-9. PubMed ID: 17289129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGF-C differentially regulates VEGF-A expression in ocular and cancer cells; promotes angiogenesis via RhoA mediated pathway.
    Kumar B; Chile SA; Ray KB; Reddy GE; Addepalli MK; Kumar AS; Ramana V; Rajagopal V
    Angiogenesis; 2011 Sep; 14(3):371-80. PubMed ID: 21698469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor gene polymorphisms are associated with prognosis in ovarian cancer.
    Hefler LA; Mustea A; Könsgen D; Concin N; Tanner B; Strick R; Heinze G; Grimm C; Schuster E; Tempfer C; Reinthaller A; Zeillinger R
    Clin Cancer Res; 2007 Feb; 13(3):898-901. PubMed ID: 17289883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial progenitor cells support tumour growth and metastatisation: implications for the resistance to anti-angiogenic therapy.
    Moccia F; Zuccolo E; Poletto V; Cinelli M; Bonetti E; Guerra G; Rosti V
    Tumour Biol; 2015 Sep; 36(9):6603-14. PubMed ID: 26232913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer.
    Koukourakis MI; Papazoglou D; Giatromanolaki A; Bougioukas G; Maltezos E; Sivridis E
    Lung Cancer; 2004 Dec; 46(3):293-8. PubMed ID: 15541813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis.
    Jin Q; Hemminki K; Enquist K; Lenner P; Grzybowska E; Klaes R; Henriksson R; Chen B; Pamula J; Pekala W; Zientek H; Rogozinska-Szczepka J; Utracka-Hutka B; Hallmans G; Försti A
    Clin Cancer Res; 2005 May; 11(10):3647-53. PubMed ID: 15897560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of vascular endothelial growth factor genetic variability in cancer.
    Schneider BP; Radovich M; Miller KD
    Clin Cancer Res; 2009 Sep; 15(17):5297-302. PubMed ID: 19706811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer.
    Gong W; Wang L; Yao JC; Ajani JA; Wei D; Aldape KD; Xie K; Sawaya R; Huang S
    Clin Cancer Res; 2005 Feb; 11(4):1386-93. PubMed ID: 15746037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential vascular and transcriptional responses to anti-vascular endothelial growth factor antibody in orthotopic human pancreatic cancer xenografts.
    Bockhorn M; Tsuzuki Y; Xu L; Frilling A; Broelsch CE; Fukumura D
    Clin Cancer Res; 2003 Sep; 9(11):4221-6. PubMed ID: 14519649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF).
    Ling MT; Lau TC; Zhou C; Chua CW; Kwok WK; Wang Q; Wang X; Wong YC
    Carcinogenesis; 2005 Oct; 26(10):1668-76. PubMed ID: 15905202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor pathway polymorphisms as prognostic and pharmacogenetic factors in cancer: a systematic review and meta-analysis.
    Eng L; Azad AK; Habbous S; Pang V; Xu W; Maitland-van der Zee AH; Savas S; Mackay HJ; Amir E; Liu G
    Clin Cancer Res; 2012 Sep; 18(17):4526-37. PubMed ID: 22733538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between osteopontin and vascular endothelial growth factor: Implications for cancer.
    Ramchandani D; Weber GF
    Biochim Biophys Acta; 2015 Apr; 1855(2):202-22. PubMed ID: 25732057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and analysis of in vivo VEGF downstream markers link VEGF pathway activity with efficacy of anti-VEGF therapies.
    Brauer MJ; Zhuang G; Schmidt M; Yao J; Wu X; Kaminker JS; Jurinka SS; Kolumam G; Chung AS; Jubb A; Modrusan Z; Ozawa T; James CD; Phillips H; Haley B; Tam RN; Clermont AC; Cheng JH; Yang SX; Swain SM; Chen D; Scherer SJ; Koeppen H; Yeh RF; Yue P; Stephan JP; Hegde P; Ferrara N; Singh M; Bais C
    Clin Cancer Res; 2013 Jul; 19(13):3681-92. PubMed ID: 23685835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The positive correlation between gene expression of the two angiogenic factors: VEGF and BMP-2 in lung cancer patients.
    Bieniasz M; Oszajca K; Eusebio M; Kordiak J; Bartkowiak J; Szemraj J
    Lung Cancer; 2009 Dec; 66(3):319-26. PubMed ID: 19324447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.
    Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC
    Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression and clinical significance of pSTAT3, VEGF and VEGF-C in pancreatic adenocarcinoma.
    Huang C; Huang R; Chang W; Jiang T; Huang K; Cao J; Sun X; Qiu Z
    Neoplasma; 2012; 59(1):52-61. PubMed ID: 22082308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.